60 results
S-1/A
EX-3.2
IMPL
Impel Pharmaceuticals Inc
19 Apr 21
IPO registration (amended)
6:10am
of the holders of a majority of the voting power of all of the then-outstanding shares of the capital stock of the Corporation entitled to vote … ”). Any adoption, amendment or repeal of the Bylaws by the Board shall require the approval of a majority of the Whole Board. The stockholders shall also
S-1
EX-3.1
IMPL
Impel Pharmaceuticals Inc
2 Apr 21
IPO registration
3:04pm
of the Corporation representing a majority of the votes represented by all outstanding shares of capital stock of the Corporation entitled to vote … to the Series A Preferred Stock, the Series B Preferred Stock, and the Series C Preferred Stock, the holders of a majority of the then outstanding shares
S-1/A
EX-3.1
IMPL
Impel Pharmaceuticals Inc
19 Apr 21
IPO registration (amended)
6:10am
vote of the holders of shares of capital stock of the Corporation representing a majority of the votes represented by all outstanding shares of capital … of a majority of the then outstanding shares of Series B Preferred Stock and Series C Preferred Stock, consenting or voting together as a single class
S-1
EX-3.3
IMPL
Impel Pharmaceuticals Inc
2 Apr 21
IPO registration
3:04pm
ten percent (10%) of the total number of votes entitled to be cast by all stockholders at such meeting, or by a majority of the “Whole Board,” which … may not be called by any other person or persons. If a special meeting of stockholders is called by any person or persons other than by a majority
S-1/A
EX-3.3
IMPL
Impel Pharmaceuticals Inc
19 Apr 21
IPO registration (amended)
6:10am
that are entitled to cast not less than ten percent (10%) of the total number of votes entitled to be cast by all stockholders at such meeting, or by a majority … other than by a majority of the members of the Board, then such person or persons shall request such meeting by delivering a written request to call
10-Q
EX-3.1
zr0f1jl4o6r
7 Jun 21
Quarterly report
7:17am
8-K
EX-10.1
sjtk3z8llq1kn4x72840
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
S-1/A
EX-3.4
ist71
19 Apr 21
IPO registration (amended)
6:10am
424B5
lfkfjnhm8gmlegc7fcm
24 May 22
Prospectus supplement for primary offering
4:32pm
10-Q
EX-3.2
xt639f78x
7 Jun 21
Quarterly report
7:17am
S-3
bk7aq5kgn4l2n50
16 May 22
Shelf registration
4:49pm
S-3
EX-4.3
o4g5bii2ox
16 May 22
Shelf registration
4:49pm
10-K/A
EX-3.2
brfherqo
31 Mar 23
Annual report (amended)
4:21pm
S-1
EX-4.3
kvyuzdfi99q 04j0o5g
2 Apr 21
IPO registration
3:04pm
S-1/A
EX-10.1
ne7l405h35xr8foxd
19 Apr 21
IPO registration (amended)
6:10am
S-3
EX-4.4
tpv7r2eso1k5za
16 May 22
Shelf registration
4:49pm
S-1
EX-4.2
axuv54hblae 5uj
2 Apr 21
IPO registration
3:04pm
S-1/A
EX-10.8
ttucpvjzg5up7n
19 Apr 21
IPO registration (amended)
6:10am
PRE 14A
gt8bb3ygesyol cc
14 Apr 23
Preliminary proxy
4:11pm